Nutlin-C1-amido-PEG4-C2-N3

Background Introduction

Nutlin-C1-amido-PEG4-C2-N3 is a specially engineered E3 ligase ligand-linker conjugate designed for use in the development of Proteolysis Targeting Chimeras (PROTACs). This compound features a Nutlin-based ligand that specifically binds the MDM2 E3 ligase, connected to an azide-terminated polyethylene glycol (PEG4) linker. The modular design of Nutlin-C1-amido-PEG4-C2-N3 enables researchers to create custom PROTAC molecules for targeted protein degradation applications.

Mechanism

The mechanism of Nutlin-C1-amido-PEG4-C2-N3 centers on targeted protein degradation via the ubiquitin-proteasome system. When incorporated into a bifunctional PROTAC molecule, the Nutlin moiety binds to the MDM2 E3 ubiquitin ligase, while the azide group at the end of the PEG4 linker allows for click chemistry attachment to a ligand that targets the protein of interest. Upon binding both the E3 ligase and the target protein, the PROTAC induces proximity-driven ubiquitination of the target, marking it for proteasomal degradation and thereby reducing its cellular levels.

Applications

Nutlin-C1-amido-PEG4-C2-N3 is widely used in the research and development of novel PROTACs aimed at selective protein degradation. Its MDM2-targeting capability makes it especially suitable for applications in oncology, cell signaling, and protein homeostasis studies. Researchers use Nutlin-C1-amido-PEG4-C2-N3 to design and synthesize next-generation small molecules for target validation, drug discovery, and the exploration of disease-relevant signaling pathways. Additionally, the azide functionality enables easy conjugation with a wide range of ligands, offering flexibility in designing PROTACs for customized therapeutic or research purposes.

• Nutlin-derived ligand ensures high affinity and selectivity for MDM2, enabling effective targeted protein degradation in PROTAC applications.
• PEG4 linker and terminal azide group provide superior solubility and versatile conjugation options for customizable PROTAC design and bioconjugation strategies.

The Nutlin-C1-amido-PEG4-C2-N3 E3 Ligase Ligand-Linker Conjugate plays a crucial role in PROTACs by facilitating targeted protein degradation. It offers enhanced selectivity and efficacy in degrading specific proteins, making it valuable for research applications. The following provides a detailed description of this molecule's linker, ligand, and selection of target protein ligands.

Linker: The linker in this molecule is a PEG4 chain, which provides optimal flexibility and hydrophilicity. Its moderate length allows for efficient bridging between the ligand and the target protein. The linker is non-cleavable, ensuring stability during the degradation process.

Ligand: The ligand component is based on Nutlin-C1, a potent MDM2 antagonist. Its structural characteristics include a high affinity for the E3 ligase, enabling effective recruitment of the ubiquitin-proteasome system for targeted protein degradation.

Reactive Site: The molecule features an azide group at the C2 position, which couples with the target protein ligand through click chemistry reactions such as CuAAC. This site allows for robust and selective conjugation, enhancing the overall efficiency of the PROTAC.

Recommended Target Protein Ligand: The recommended warhead for this molecule is an alkyne-functionalized ligand. This warhead is advantageous due to its ability to form stable triazole linkages via click chemistry, ensuring a strong and specific interaction with the target protein. This approach is ideal for applications requiring precise protein degradation, advancing research in targeted therapeutics.